These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12397516)

  • 1. [Do psychological factors change in patients with spasmodic dysphonia after injections with botulinum-toxin?].
    Kiese-Himmel C; Reeh M; Liebeck H; Zwirner P
    Laryngorhinootologie; 2002 Oct; 81(10):683-9. PubMed ID: 12397516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
    Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
    Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
    Paniello RC; Barlow J; Serna JS
    Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of spasmodic dysphonia with botulinum toxin].
    Vilkman E; Laurikainen E; Marttila R
    Duodecim; 1995; 111(16):1546-51. PubMed ID: 9273263
    [No Abstract]   [Full Text] [Related]  

  • 8. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes.
    Novakovic D; Waters HH; D'Elia JB; Blitzer A
    Laryngoscope; 2011 Mar; 121(3):606-12. PubMed ID: 21298641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychological factors in spasmodic dysphonia].
    Kiese-Himmel C; Zwirner P
    Laryngorhinootologie; 1996 Jul; 75(7):397-402. PubMed ID: 8924167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and demographics in patients with spasmodic dysphonia.
    Schweinfurth JM; Billante M; Courey MS
    Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP; Morrison MD
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
    Chang CY; Chabot P; Thomas JP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vocal outcome measures after bilateral posterior cricoarytenoid muscle botulinum toxin injections for abductor spasmodic dysphonia.
    Klein AM; Stong BC; Wise J; DelGaudio JM; Hapner ER; Johns MM
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):421-3. PubMed ID: 18722224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.